Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective: To assess whether neuropsychological tests and MRI measures could be used as predictors of short-term disease evolution in a population of patients with benign multiple sclerosis (B-MS).
Background: The definition of B-MS is controversial. Recent data suggest that neuropsychological tests and MRI measures can provide valuable information for a more correct definition and interpretation of B-MS.
Methods: Sixty-three patients with B-MS (Expanded Disability Status Scale [EDSS] ≤3.0 and disease duration ≥15 years) underwent neuropsychological assessment using the Rao's Brief Repeatable Neuropsychological Battery and the Stroop Test. At that time, conventional brain MRI and magnetization transfer (MT) imaging was performed. White matter lesion load, global and regional brain volumes, and MT ratio in lesions and normal-appearing brain were measured. After a mean follow-up of 5 years, patients still having an EDSS score ≤3.5 were classified as still benign, whereas patients who had developed a secondary progressive course or who had an EDSS score ≥4.0 were defined as no longer benign (NLB).
Results: At end of follow-up, 29% of patients were classified as NLB. Male gender (hazard ratio [HR] = 2.9; 95% confidence interval [CI] 1.2–7.5; p = 0.02), number of neuropsychological tests failed (HR = 1.4; 95% CI 1.1–1.7; p = 0.003), and T1-weighted lesions (HR = 1.3; 95% CI 1.1–1.5; p = 0.002) were related to NLB status. In a model including these 3 variables, the NLB status was predicted with an accuracy of 82%.
Conclusions: Cognitive assessment and MRI metrics can predict short-term disease evolution in benign multiple sclerosis (B-MS). This information can be useful to correctly identify patients with B-MS.
Glossary
- AC=
- anterior commissure;
- B-MS=
- benign multiple sclerosis;
- BRB=
- Brief Repeatable Neuropsychological Battery;
- CI=
- confidence interval;
- EDSS=
- Expanded Disability Status Scale;
- HR=
- hazard ratio;
- LV=
- lesion volume;
- MT=
- magnetization transfer;
- MTr=
- MT ratio;
- NBV=
- normalized brain volume;
- NCV=
- normalized cortical volumes;
- NLB=
- no longer benign;
- PASAT=
- Paced Auditory Serial Addition Test;
- PC=
- posterior commissure;
- SB=
- still benign;
- SDMT=
- Symbol Digit Modalities Test;
- SP=
- secondary progressive;
- SPART=
- Spatial Recall Test;
- SRT=
- Selective Reminding Test;
- ST=
- Stroop Test;
- TE=
- echo time;
- TR=
- repetition time;
- WLG=
- Word List Generation.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
More Online
Dr. Jessica Ailani and Dr. Ailna Masters-Israilov
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Articles
Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosisM. P. Amato, E. Portaccio, M. L. Stromillo et al.Neurology, August 25, 2008 -
Articles
A magnetization transfer histogram study of normal-appearing brain tissue in MSC. Tortorella, B. Viti, M. Bozzali et al.Neurology, January 11, 2000 -
Articles
Comparison of MS clinical phenotypes using conventional and magnetization transfer MRIM. Filippi, G. Iannucci, C. Tortorella et al.Neurology, February 01, 1999 -
Article
Gray matter damage predicts the accumulation of disability 13 years later in MSMassimo Filippi, Paolo Preziosa, Massimiliano Copetti et al.Neurology, October 11, 2013